☆ 4.7 Article

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ANNALS OF ONCOLOGY (2018)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 29, Issue -, Pages 192-237

Publisher

ELSEVIER
DOI: 10.1093/annonc/mdy275

Keywords

-

Categories

Oncology

Funding

  1. AstraZeneca
  2. Roche
  3. Novartis
  4. prIME Oncology
  5. Pfizer
  6. Boehringer Ingelheim
  7. Epizyme
  8. Bristol-Myers Squibb
  9. Clovis Oncology
  10. Lilly
  11. Takeda
  12. Merck Sharpe Dohme
  13. Merck Sharp and Dohme
  14. SFJ Pharmaceuticals
  15. XCovery
  16. Boehringer-Ingelheim
  17. Clovis
  18. Eli Lilly
  19. F. Hoffrnann-La Roche
  20. Janssen
  21. Merck Sharp Dohme
  22. Merck Serono
  23. Regeneron

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.